Form 8-K - Current report:
SEC Accession No. 0001299933-12-002152
Filing Date
2012-09-19
Accepted
2012-09-19 09:45:44
Documents
3
Period of Report
2012-09-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_46038.htm 8-K 9921
2 EX-99.1 exhibit1.htm EX-99.1 8222
3 GRAPHIC e36977-12262174255159b8e2_1.jpg GRAPHIC 24717
  Complete submission text file 0001299933-12-002152.txt   53378
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 121098895
SIC: 2834 Pharmaceutical Preparations